AJP - Heart AJP: Lung Cellular and Molecular Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 277: H1661-H1668, 1999;
0363-6135/99 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ratz, P. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ratz, P. H.
Vol. 277, Issue 5, H1661-H1668, November 1999

Dependence of Ca2+ sensitivity of arterial contractions on history of receptor activation

Paul H. Ratz

Department of Physiological Sciences, Eastern Virginia Medical School, Norfolk, Virginia 23501


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Stimulation of receptors causing arterial contraction may also cause attenuation of cell responsiveness to stimuli. This study tested the hypothesis that attenuation of receptor-induced contractions involves Ca2+ desensitization. Renal artery rings were pretreated with 10 µM phenylephrine (PE), relaxed with PE washout (plus phentolamine), and then activated by histamine (HA). Pretreatment for 30 min resulted in a rightward shift in the concentration-contraction curve to HA by ~1/2 log without a reduction in the slope or maximum response. For example, control and PE-pretreated tissues responded to 0.56 µM HA with strong (0.95 F/Fo) and weak (0.16 F/Fo) contractions, respectively, where F/Fo represents contractile force. This reduced reactivity was completely reversed within 90 min. In fura-loaded tissues, PE pretreatment caused less of a rightward shift in the HA concentration-intracellular free Ca2+ concentration ([Ca2+]i) curve than in the HA concentration-contraction curve. A dissociation between force and [Ca2+]i was also produced when KCl was used instead of HA. These data suggest that the reduced reactivity produced by PE pretreatment involved, in part, a reduction in the ability of HA to increase the Ca2+ sensitivity of contractions. These data support the hypothesis that the degree of stimulus-induced Ca2+ sensitization of contractions is dependent on the history of receptor activation.

heterologous desensitization; fura 2; rabbit renal artery; isometric force; phenylephrine; histamine; vascular smooth muscle


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

AN EPISODE OF EXPOSURE to a G protein-linked receptor stimulus not only causes an immediate response but also may induce desensitization, causing the tissue to subsequently display decreased reactivity to receptor stimuli (26). The classic explanation for this attenuation of cell responsiveness to a ligand is receptor desensitization (19, 26). However, several lines of evidence suggest that reductions in postreceptor signaling systems may also play a role (3, 9, 16, 22, 30).

Homologous and heterologous desensitization are the terms currently used to describe the overall phenomenon of postactivation attenuation of cell responsiveness (19, 26). Homologous receptor desensitization involves a reduction in same-receptor responsiveness. The mechanisms behind this effect have been rigorously studied by Lefkowitz and others (19), who show, for example, that beta -adrenergic receptor stimulation can activate receptor kinases, leading to beta -adrenergic receptor desensitization and ultimately to a reduction in beta -adrenergic receptor numbers. Heterologous desensitization is, by definition, a more complex modulatory mechanism consisting of desensitization of receptors other than that stimulated to cause the desensitization or desensitization resulting from modulation of postreceptor signaling systems (26).

Desensitization of vascular smooth muscle contractions is a well-known phenomenon, but the precise subcellular mechanisms responsible for this adaptive response remain to be determined. Homologous alpha -adrenergic receptor desensitization occurs in cultured vascular smooth muscle cells, but to induce this response, cells appear to require stimulation periods in excess of several hours (3, 11). Interestingly, stimulation of intact rat arterial muscle with epinephrine for 12 h does not reduce alpha -adrenergic receptor numbers or affinity, but alpha -receptor-induced contractile activity is greatly diminished, implying that postreceptor desensitization is activated by the prolonged receptor stimulation period (16).

Recent evidence shows that shorter episodes of receptor activation (<1 h) of rabbit femoral artery (22), hog carotid artery (30), or rabbit detrusor (28) reduce KCl-induced contractile activity. Because KCl produces contractions by causing membrane depolarization rather than acting as a receptor stimulus, these results indicate that short periods of receptor stimulation can desensitize signaling systems downstream from receptor activation in smooth muscle.

If receptor stimulation can reduce reactivity of smooth muscle to KCl by activating a postreceptor desensitizing mechanism, then stimulation of a receptor type other than that used to produce desensitization may also be affected by this mechanism. One modulatory mechanism that plays a key role in regulation of smooth muscle contractile reactivity involves changes in the Ca2+ sensitivity of contractions (29). In particular, receptor agonists increase Ca2+ sensitivity, whereas agents that increase cGMP decrease Ca2+ sensitivity (12, 13). In short, by changing Ca2+ sensitivity, the level of contraction may be greatly increased or decreased without considerable changes in the concentration of cytosolic free Ca2+ ([Ca2+]i). The goal of the present study was to test the hypothesis that heterologous postreceptor desensitization involves, at least in part, a reduction in Ca2+ sensitivity of receptor-induced contractions.


    METHODS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Tissue preparation. Tissues were prepared as described previously (22). Renal arteries obtained from female New Zealand White rabbits were cleaned of adhering tissue and stored for <= 48 h in cold (0-4°C) physiological saline solution (PSS) composed of (in mM) 140 NaCl, 4.7 KCl, 1.2 MgSO4, 1.6 CaCl2, 1.2 Na2HPO4, 2.0 MOPS (adjusted to pH 7.4 at either 0 or 37°C, as appropriate), 0.02 Na2-EDTA (to chelate trace heavy metals), and 5.6 D-glucose. High-purity (>17 MOmega distilled and deionized) water was used throughout. Before arterial muscle rings were secured between a micrometer and an isometric force transducer (model 52, Harvard Apparatus, South Natick, MA) in water-jacketed muscle chambers (Radnoti Glass Technology, Monrovia, CA), the endothelium was removed by gently rubbing the intimal surface with a metal rod, and the adventitia was removed by microdissection.

Isometric contractions were measured as described previously (22). Voltage signals from force transducers were digitized (model DAS-16, MetraByte, Taunton, MA), visualized on a computer screen as force (in g), and stored by software command to a hard disk for later analyses. All data analyses were accomplished with the use of customized compiled BASIC programs or DasyLab (DasyTec, Amherst, NH) and an electronic spread sheet.

Isometric force. Contractile force (F) was measured as described previously (22). Tissues were allowed to equilibrate at 37°C for 1 h, and the muscle length at which active force was maximum (Lo) was then determined for each tissue with K+ as agonist (110 mM KCl substituted isosmotically for NaCl) using an abbreviated length-tension curve (8, 22). Once tissues were stretched to Lo, no further length changes were imposed. For each tissue, the degree of steady-state F produced at Lo by incubation for 5-10 min in 110 mM KCl was equal to the optimal force for muscle contraction (Fo), and subsequent contractions were calculated as F/Fo. Tissues contracted with phenylephrine (PE) were relaxed by PE washout in the presence of 1 µM phentolamine (alpha -adrenergic receptor antagonist). In tissues contracted with histamine (HA), 1 µM cimetidine (H2-receptor blocker) was added 10 min before the addition of HA. In tissues contracted with KCl, 1 µM phentolamine was added to block potential alpha -adrenergic receptor activation caused by the release of norepinephrine from periarterial nerves. To perform concentration-response curves, HA or KCl was added cumulatively every 7-10 min.

Intracellular free Ca2+ concentration. [Ca2+]i was measured as described previously (24). Arterial rings secured between a micrometer and an isometric force transducer and positioned in front of a quartz window in a custom-fabricated water-jacketed muscle chamber (Radnoti Glass Technology) were loaded for 2.5 h with 10 µM fura 2-AM (Molecular Probes, Eugene, OR) plus Pluronic F-127 (0.01% wt/vol) to enhance solubility. Tissues were washed for 30 min and, in response to alternate excitation at 340 and 380 nm with the use of a rotating filter wheel, fluorescence emissions at 500 nm for each excitation wavelength (F340 and F380) were collected by a photomultiplier tube and amplified (model 1642, Ithaco), digitized (Data Translations DT2811), and visualized on a computer screen (CODAS software package, DATAQ Instruments). [Ca2+]i (in nM) was calculated using the formula [Ca2+]i = [(R - Rmin)/(Rmax - R)] × (Sf/Sb) × Kd, where Rmin and Rmax are the ratios produced, respectively, in a Ca2+-free solution (PSS containing 0 mM CaCl2, 5 mM EGTA, 110 mM KCl substituted for NaCl, and 20 µM ionomycin) and in the presence of excess Ca2+ (PSS containing 3.6 mM CaCl2, 110 mM KCl substituted for NaCl, and 20 µM ionomycin); Sf/Sb is the ratio of F380 in the Ca2+-free solution to F380 in the presence of excess Ca2+; and Kd is the dissociation constant (224 nM) (7). All fluorescence measurements were corrected for tissue background fluorescence by adding 4 mM MnCl2 to the Rmax solution to quench the fura 2 signal at the end of the experiment. Fluorescence ratios (F340/F380) taken in resting (0.36 ± 0.01) and fully contracted (0.36 ± 0.01, n = 21, P > 0.05) tissues before being loaded with fura 2-AM were not different, indicating that contractions, per se, had no effect on ratiometric tissue fluorescence. Furthermore, a comparison of F340 and F380 fluorescence values taken after the 4 mM MnCl2 quench at the end of the experiment (0.35 ± 0.03 and 1.06 ± 0.11, respectively) with those values taken before the fura 2-AM loading (0.33 ± 0.03 and 0.97 ± 0.11, respectively, n = 21, P > 0.05) were not different, suggesting that signal interference from fluorescent intermediates potentially produced by partial hydrolysis of fura 2-AM was negligible.

Statistics. For analyses of concentration-response data for each tissue, a curve-fitting program (GraphPad) was used to obtain the four parameters of a sigmoidal curve [maximum, minimum, slope, and concentration producting half-maximum contraction (EC50)]. For statistical analyses of logarithmic data (i.e., EC50 values), geometric means were used (5). For convenience, log EC50 values were converted to EC50 values in micromoles per liter in the text. To construct Fig. 5, Ca2+ values for each tissue were converted so that values ranged between 0 and 1. This was accomplished by dividing the difference between the agonist-stimulated value and the curve-fitted minimum value (in nM) by the difference between the curve-fitted maximum and minimum values (in nM), represented as Ca/Camax.

The null hypothesis was examined using one-way ANOVA. To determine differences between groups, the Student-Newman-Keuls post hoc test was used. When two groups were compared, the Student's t-test was used. In all cases, the null hypothesis was rejected at P < 0.05. For each study described, the value of n was equal to the number of rabbits from which arteries were obtained.


    RESULTS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Effect of PE pretreatment on HA-induced contractions. An HA-induced concentration-contraction curve produced in rabbit renal artery not loaded with the Ca2+ indicator fura 2 (Fig. 1) was characterized by an EC50 of 0.30 ± 0.06 µM, a slope of 4.75 ± 0.70, and a maximum response of 1.01 ± 0.01 F/Fo (n = 3). In tissues pretreated for 30 min with 10 µM PE and washed for 10 min before addition of the first HA concentration, the HA-induced concentration-contraction curve was characterized by an ~1/2 log rightward shift in the EC50 to 0.93 ± 0.08 µM (P < 0.05 compared with control) without a change in the slope (3.94 ± 0.69) or maximum response (0.96 ± 0.04 F/Fo, n = 3; Fig. 1).


View larger version (22K):
[in this window]
[in a new window]
 
Fig. 1.   Histamine (HA) concentration-contraction curves produced in control tissues and tissues pretreated for 30 min with 10 µM phenylephrine (PE). Duration of time between washout of PE and addition of the first HA concentration ([Histamine]) was 10 min. A dotted vertical line was drawn at 0.56 µM HA to highlight large difference between contractile force (F/Fo) responses produced at this HA concentration by control and PE-pretreated tissues. Data are means ± SE; n = 3 rabbits.

The degree of reduction in reactivity to HA may have depended on three variables: the concentration of PE used during the pretreatment episode, the duration of the pretreatment episode, and the duration of time following the pretreatment episode. Because the most dramatic difference in responsiveness to HA between control and PE-pretreated tissues occurred at 0.56 µM (Fig. 1, dotted line), experiments were designed to examine all three variables and compare contractions produced by 0.56 µM HA. Under pretreatment conditions consisting of 30-min contractions with 10, 1, and 0.1 µM PE followed by relaxation for 10 min, 0.56 µM HA produced contractions of 0.16, 0.69, and 1.02 F/Fo, respectively (Fig. 2). Thus the degree of reduced reactivity to HA depended on the concentration of PE used during the pretreatment episode. The steady-state values of 0.1, 1, and 10 µM PE-induced contractions were 0.49 ± 0.11, 0.96 ± 0.01, and 0.94 ± 0.02 F/Fo, respectively. Thus, when 30-min PE-pretreatment periods were considered, a concentration greater than that required to produce an ~50% maximum contraction (i.e., >EC50) was required to cause a decrease in the ability of HA to subsequently produce a strong contraction. A shorter episode of pretreatment with 10 µM PE (10 min), followed by 10 min of relaxation, still reduced by 18% the ability of 0.56 µM HA to produce a contraction (Fig. 2). However, this 10-min pretreatment period produced a reduction in the subsequent contraction that was less than that produced by a 30-min pretreatment period (84%; Fig. 2), indicating that the longer the duration of exposure to PE, the greater the degree of desensitization of the muscle to a subsequent HA-induced contraction.


View larger version (33K):
[in this window]
[in a new window]
 
Fig. 2.   Dependency of degree of desensitization produced by PE on 1) concentration of PE and 2) duration of PE pretreatment. Dependencies were quantified by measuring relative effectiveness of 0.56 µM HA to produce contractions in control tissues and tissues pretreated with 10, 1, or 0.1 µM PE for 30 min or with 10 µM PE for 10 min. Duration of time between washout of PE and addition of HA was 10 min. Data are means ± SE; n = 4-6 rabbits. * P < 0.05 compared with control.

Finally, the degree of desensitization to HA was found to be reversible. In particular, the longer the duration of relaxation after a 30-min pretreatment period with 10 µM PE, the stronger the contraction to 0.56 µM HA (Fig. 3). In pretreated tissues relaxed for 60 min, 0.56 µM HA still produced a significantly weaker contraction than the control response (Fig. 3). Although the mean value of the response to 0.56 µM HA produced after 90 min of relaxation was less than the control value (0.77 ± 0.09 vs. 1.01 ± 05 F/Fo), this difference was not statistically significant. These data suggest that the desensitization of smooth muscle to HA induced by pretreatment for 30 min with 10 µM PE required >1 h, but probably <1.5 h, for complete reversal.


View larger version (25K):
[in this window]
[in a new window]
 
Fig. 3.   Reversibility of desensitization produced by PE pretreatment. Reversibility was quantified by measuring the degree of contraction produced by 0.56 µM HA in control tissues compared with that produced by tissues 10, 30, 60, and 90 min after pretreatment for 30 min with 10 µM PE. Data are means ± SE; n = 4-5 rabbits. * P < 0.05 compared with control.

Effect of PE pretreatment on HA-induced increases in [Ca2+]i. In tissues loaded with the Ca2+ indicator fura 2, HA produced a concentration-contraction curve that was similar to that produced by tissues not loaded with fura 2 (compare Figs. 4A and 1). In fura 2-loaded tissues, PE pretreatment (30 min at 10 µM followed by 10-min PE washout and relaxation) caused a rightward shift in the HA concentration-contraction curve as it did in tissues not loaded with fura 2 (EC50: control = 0.32 ± 0.03 µM, PE pretreated = 0.75 ± 0.05 µM, n = 4, P < 0.05; Fig. 4A). Likewise, as in tissues not fura 2 loaded, both the slope of the curve and the maximum response were not different from the control values (slope: control = 5.41 ± 0.56, PE pretreated = 4.47 ± 0.74; maximum response: control = 1.04 ± 0.02 F/Fo, PE pretreated = 1.01 ± 0.05 F/Fo). This PE pretreatment also produced a rightward shift in the HA concentration-[Ca2+]i curve (EC50: control = 0.31 ± 0.03 µM, PE pretreated = 0.54 ± 0.07 µM, n = 4, P < 0.05; Fig. 4B). However, the slope of the curve produced by tissues that had been PE pretreated was approximately twofold greater than that of the control response (slope: control = 3.71 ± 0.55, PE pretreated = 6.27 ± 0.81, n = 4, P < 0.05; Fig. 4B). The minimum and maximum [Ca2+]i responses produced by control tissues and tissues that had been pretreated with PE were identical (minimum: control = 61 ± 10 nM, PE pretreated = 62 ± 6 nM; maximum: control = 278 ± 30, PE pretreated = 266 ± 33 nM; Fig. 4B).


View larger version (19K):
[in this window]
[in a new window]
 
Fig. 4.   Effect of 10 µM PE pretreatment for 30 min on HA concentration-contraction (A; ) and HA concentration-[Ca2+]i (B; ) curves produced in tissues loaded with the Ca2+ indicator fura 2. Responses of control tissues that were not pretreated with PE are represented by open symbols. As in Fig. 1, a dotted vertical line was drawn at 0.56 µM HA. Note that 0.78 µM HA produced an increase in [Ca2+]i comparable to the control value (B), but even at 1 µM, HA did not produce an increase in contractile force that was comparable to the control value (A). Data are means ± SE; n = 4 rabbits. * P < 0.05 compared with control.

Thus a consequence of PE pretreatment was a dissociation between HA-induced increases in [Ca2+]i and contractile force. For example, 0.78 µM HA increased [Ca2+]i to the maximum level (~250 nM; see Fig. 4B), but contractile force at this HA concentration was still significantly weaker than the maximum response (~0.6 vs. ~1.0 F/Fo; see Fig. 4A). When increases in [Ca2+]i from Fig. 4 were converted to range from 0 to 1 by data normalization using sigmoidal curve-fitted maxima and minima for each tissue, it was apparent that contraction and Ca2+ displayed identical sensitivities to HA (control group EC50 values: F/Fo = 0.32 ± 0.03 µM; Ca/Camax = 0.32 ± 0.03 µM, n = 4; Fig. 5A). This was not the case in PE-pretreated tissues (Fig. 5B). Instead, [Ca2+]i was more sensitive to HA than was contraction (PE-pretreatment group EC50 values: F/Fo = 0.75 ± 0.05 µM, Ca/Camax = 0.51 ± 0.06 µM, n = 4, P < 0.05; Fig. 5B). Thus PE pretreatment produced a greater rightward shift in the HA concentration-contraction curve than in the HA concentration-[Ca2+]i curve (Fig. 5B).


View larger version (17K):
[in this window]
[in a new window]
 
Fig. 5.   Contractile force (represented as F/Fo) and cytosolic free Ca2+ (normalized as Ca/Camax) data from Fig. 4 were plotted together for control (A) and 10 µM PE-pretreated tissues (B). Data are means ± SE. Force and Ca2+ displayed identical sensitivities to HA in control (A), but Ca2+ was more sensitive to HA than was force in PE-pretreatment group (B). Thus PE pretreatment produced a greater rightward shift in the HA concentration-contraction curve than in the HA concentration-Ca2+ curve.

Relationship between HA-induced increases in contraction and [Ca2+]i. To examine the dependency of steady-state force on [Ca2+]i in tissues activated by HA, data from Fig. 5 were plotted as shown in Fig. 6A. The relationship between force and Ca/Camax for control tissues was linear, with a slope just slightly greater than unity (1.18, Fig. 6A); that is, nearly a one-to-one relationship existed between HA-induced increases in Ca2+ and force. However, in tissues that were pretreated for 30 min with 10 µM PE, the relationship between increases in Ca2+ and force was different from that produced in control tissues. When Ca2+ data were considered that showed an increase from the lowest point to the earliest point achieving near-maximum [Ca2+]i (i.e., ~250 nM [Ca2+]i produced by 0.78 µM HA; see Fig. 4B), the slope of the relationship between Ca/Camax and force was significantly less than that of the control (0.62, P < 0.05), and the maximum increase in Ca/Camax produced at 0.78 µM HA corresponded with an increase in force of 0.6 ± 0.07 F/Fo (Fig. 6A, shaded square). This force value was significantly less than the control force value (1.03 ± 0.04) that produced an identical increase in Ca/Camax of 0.92-fold Camax (Fig. 6A, shaded circle). Thus PE-pretreated tissues displayed a reduced sensitivity of contractions to increases in [Ca2+]i. Further increases in HA concentration above 0.78 µM produced additional increases in force without an additional increase in [Ca2+]i (see Fig. 4B), suggesting that tissues regained normal sensitivity at higher HA concentrations or with a combination of higher HA concentrations and time. These data were similar to those produced when tissues were stimulated with increasing KCl concentrations rather than increasing HA concentrations (Fig. 6B); that is, after pretreatment of tissues for 30 min with 10 µM PE followed by a 10-min relaxation period, 25 mM KCl (Fig. 6B, shaded square) produced an increase in Ca/Camax statistically identical to that produced by control tissues stimulated with 40 mM KCl (Fig. 6B, shaded circle), but produced a much weaker increase in force (0.20 ± 0.08 vs. 0.73 ± 0.06 F/Fo, P < 0.05) (Fig. 6B). The relationship between Ca2+ and force for KCl-stimulated tissues fit an exponential better than a linear curve; that is, r2 values for exponential and linear curve fits were, respectively, 0.92 and 0.83 for control data and 0.85 and 0.53 for PE-pretreatment data. The reason for the apparent difference in the form of the relationship between force and Ca2+ when HA and KCl were compared was not pursued further. The Ca2+-force curve produced by tissues stimulated with KCl and pretreated with PE was significantly different from the KCl-stimulated control curve (P < 0.05). Interestingly, when these four plots were compared together, for a given moderate increase in Ca2+ (e.g., 0.7-fold Camax; Fig. 7, dotted lines), tissues from the HA control group produced the highest force (~0.7-fold Fo), KCl after PE-pretreatment produced the lowest force (~0.2-fold Fo), and HA after PE pretreatment or KCl control fell in between these extremes (~0.4-fold Fo) (Fig. 7).


View larger version (22K):
[in this window]
[in a new window]
 
Fig. 6.   Ca2+ desensitization demonstrated by analyses of dependencies of force on Ca2+ in control tissues (open symbols) compared with tissues pretreated with 10 µM PE (filled symbols) and stimulated 10 min after PE washout with increasing concentrations of HA (A) or KCl (B). In PE-pretreated tissues, low concentrations of both HA and KCl produced increases in Ca2+ equivalent to those produced in control tissues, but these increases in Ca2+ produced significantly weaker increases in force (shaded symbols, means ± SE; see text). Thus PE-pretreated renal arterial muscle was desensitized to increases in Ca2+. m, Slope.



View larger version (25K):
[in this window]
[in a new window]
 
Fig. 7.   Summary of dependencies of contractile force on Ca2+ showing relative relationships in tissues stimulated with HA and KCl in naive tissues (not PE pretreated) and in tissues with a history of PE pretreatment (10 µM PE for 30 min followed by 10-min PE washout). Dotted lines indicate that a wide range of forces may be produced by a given increase in Ca2+ (see text for further description).


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

The degree of reactivity of renal artery to HA was found to be dependent on the recent history of receptor activation. For example, stimulation of rabbit renal artery alpha 1-adrenergic receptors with 10 µM PE for a short duration (30 min) reduced the ability of this tissue to subsequently respond to stimulation by another receptor type, H1-histaminergic receptors, for <= 90 min after cessation of the initial PE stimulation. Reduced reactivity to HA may have been caused by reductions in H1-receptor numbers, receptor-G protein coupling, or other components of stimulus-contraction coupling beyond receptor activation, such as Ca2+ mobilization or regulation of Ca2+ sensitivity of contractions. This is the first study to provide evidence in support of the hypothesis that the degree of receptor-stimulated Ca2+ sensitization of contractions can be reversibly attenuated by a prior short episode of receptor activation.

One important regulatory mechanism that operates downstream from receptor activation involves changes in the degree of Ca2+ sensitivity of contractions (12, 17, 29). Receptor stimulation immediately increases the Ca2+ sensitivity of contractions by activation of the low-molecular-weight G protein RhoA (6), resulting in a force-to-[Ca2+]i ratio greater than that produced by K+-depolarization (12, 29); that is, the level of force produced for a given level of [Ca2+]i is greater during receptor activation than during K+-depolarization (12). Moreover, the two major physiological mechanisms causing smooth muscle relaxation, namely, increases in cGMP and cAMP, cause reductions in Ca2+ sensitivity (12, 13, 14). However, contractile receptor ligands and agents that elevate cellular levels of cyclic nucleotides also alter [Ca2+]i (12, 23). Thus smooth muscle utilizes at least two mechanisms to regulate the level of contraction, namely, changes in [Ca2+]i and changes in Ca2+ sensitivity.

In the present study, prior exposure of rabbit renal artery to 10 µM PE for only 30 min caused a greater reduction in the sensitivity of HA-induced contractions than of HA-induced increases in [Ca2+]i; that is, PE pretreatment reduced the ability of HA to increase force more than it reduced the ability of HA to increase [Ca2+]i. Thus the most novel aspect of the work presented here is the evidence suggesting that alpha 1-adrenergic receptors can induce a mechanism that temporarily reduces the ability of receptor stimuli to subsequently produce increases in Ca2+ sensitivity of contractions. The significance of this finding is that it adds a new dimension to receptor-induced alterations in Ca2+ sensitivity. These data support the hypothesis that the degree of increase in Ca2+ sensitivity is a variable dependent on the activation history of the vascular smooth muscle cell. In this scenario, naive cells would produce greater increases in Ca2+ sensitivity than cells that had recently been stimulated with a maximum concentration of contractile receptor agonist.

Attenuation of cell responsiveness to extracellular ligands is a well-known cellular regulatory mechanism that may function to maintain target cell function within normal, physiological limits (19, 26). Currently, the primary explanation for receptor-induced attenuation of cell responsiveness is receptor-response uncoupling and subsequent reductions in receptor numbers (19). However, studies of smooth muscle show that a reduction in the numbers or affinity of alpha -adrenergic receptors to agonists is not sufficient to explain reductions in agonist reactivity (3, 16). An alternative explanation is that some agonists not only stimulate contractions but also may induce desensitization of signaling systems downstream from the receptor. Perhaps the strongest argument that postreceptor mechanisms play a role in short-term receptor-induced attenuation of responsiveness is that the strength of KCl-induced contractions can be reduced in arteries with a history of receptor activation (22, 30). KCl bypasses receptors, producing contractions by causing membrane depolarization. Thus the subsequent reduction in tissue reactivity to KCl caused by pretreatment with a receptor ligand could not be the result of receptor downregulation but must be due to some postreceptor desensitization of cell signaling.

If receptor activation is required to activate RhoA to increase Ca2+ sensitivity, then in cells activated by KCl, RhoA should not be activated, and Ca2+ sensitivity should be low. However, a recent study (25) and data from the present study show that PE pretreatment reduces the Ca2+ sensitivity of KCl-induced contractions, suggesting that RhoA is activated by KCl, as well as by receptor ligands, or that RhoA is basally active. A recent study suggests that the former case is more likely because incubation of portal vein with DC3B, a cell-permeable inhibitor of RhoA, significantly inhibited KCl-induced contractions but had no effect on the pCa-tension curve in alpha -toxin-permeabilized tissues (6). Moreover, Yanagisawa and Okada (31) have shown that K+ depolarization increases Ca2+ sensitivity of arterial contractions. These data taken together support the hypothesis that RhoA is not active in resting vascular smooth muscle but that both receptor activation and membrane depolarization induce RhoA activation leading to increases in Ca2+ sensitivity and that the ability of either a receptor ligand or KCl to activate RhoA may be reduced by prior strong receptor activation. Moreover, data from the present study support the hypothesis that only in naive arteries do receptor agonists increase Ca2+ sensitivity above that produced by KCl, whereas in arteries with a recent history of strong receptor activation, agonist-induced Ca2+ sensitization may not necessarily exceed that produced by KCl. For example, in arteries pretreated with 10 µM PE for 30 min and then relaxed for 10 min (i.e., in arteries with a history of alpha 1-adrenergic receptor activation), HA-induced Ca2+ sensitization was roughly equivalent to that induced by KCl (see Fig. 7).

Activation of the modulatory mechanism resulting in reduced reactivity to HA was dependent on both the concentration of PE and duration of alpha 1-receptor stimulation. Moreover, the modulatory mechanism was completely reversible, suggesting that it was a physiologically relevant mechanism and not due to rundown of the tissue. Reduced reactivity to HA was evident when tissues were pretreated with PE for as a short a duration as 10 min, but the concentration of PE required to reduce subsequent HA reactivity was greater than that required to produce half-maximum contractions. Thus, compared with alpha -adrenergic receptor downregulation in vascular smooth muscle, which appears to take many hours to occur (3, 11, 16), this modulatory mechanism was "switched on" very rapidly. Moreover, although desensitization did not occur at low levels of receptor activation, very high concentrations were also not required. PE is less potent than norepinephrine at causing contractions in rabbit renal arteries. For example, 10 µM PE and 0.32 µM norepinephrine produce nearly equivalent activation of arteries (18). Because intra- and perisynaptic norepinephrine concentrations in the rabbit ear artery range from 0.5 to 0.7 µM, and those in guinea pig uterine artery and rat portal vein are ~10 µM (1), muscle activation by 10 µM PE may be regarded as reflecting levels of alpha 1-adrenergic stimulation within the moderate-to-high physiological range.

Vascular smooth muscle cells contain many more receptors than are required to produce maximum responses (i.e., the receptors are spare in number; Ref. 27). For example, to produce half-maximum contractions in rabbit ear artery requires activation of as little as 1% of the total alpha -adrenergic receptor pool (20), and maximum contractions are achieved in rabbit renal arteries when only 23% of the total alpha -adrenergic receptors are occupied (21). The precise role that spare receptors play in normal physiology is a matter of speculation. However, it is clear that spare receptors are not functionally distinct receptors but are simply "extra" receptors that, when stimulated, do not contribute further to the particular response measured because the response is already maximal (2). Results from the present study support the notion that, in rabbit arterial smooth muscle, one function of spare receptors is to "notify" the cell that enough receptor ligand exists in the extracellular milieu to produce maximum contractions. This "notification" involves, in part, activation of a signaling system targeting Ca2+ sensitivity of the contractile apparatus such that the ability of receptor stimuli to increase Ca2+ sensitivity is temporarily attenuated.

PE pretreatment caused a rightward shift in both HA-contraction and HA-[Ca2+]i curves. The finding that the HA-contraction curve was shifter farther to the right than the HA-[Ca2+]i curve indicated that PE-pretreatment induced a decrease in Ca2+ sensitivity. However, the fact that the HA-[Ca2+]i curve was shifted to the right compared with that for control tissues suggests that PE pretreatment also induced a dissociation between receptor activation and mobilization of [Ca2+]i. Additional studies are required to determine whether this effect involved alterations in the type or efficacy of linkage between activated receptors and G proteins or in regulation of Ca2+ influx, release, uptake, or efflux. Indeed, there are several exciting possibilities to be examined on the basis of recent literature. With the advent of the three-state model of receptor activation (15), changes in agonist potency may be explained by changes in active conformation and G protein coupling, and it may be proposed that PE pretreatment reduced the effectiveness of receptor-G protein coupling. Regulators of G protein signaling (RGS) proteins accelerate GTP hydrolysis of Galpha subunits and have been implicated as effector antagonists (10). Thus enhanced RGS activity produced by PE pretreatment could theoretically have reduced the potency of HA-induced increases in [Ca2+]i. Lastly, Ca2+ channels and pumps are known to be regulated, and PE-induced downregulation of Ca2+ influx through L-type Ca2+ channels has been shown to occur in vascular smooth muscle (4).

In summary, the present study indicates that alpha 1-adrenergic receptor activation in rabbit renal artery not only caused strong contractions but also initiated a mechanism causing subsequent attenuation of reactivity to HA, as reflected by a large (~1/2 log) rightward shift in the HA-contraction curve and a moderate (~1/4 log) rightward shift in the HA-[Ca2+]i curve. These dramatic effects were produced after only a 30-min stimulation with 10 µM PE, but the reduced reactivity completely reversed within 90 min. Because the rightward shift in the HA-[Ca2+]i curve was significantly less than the rightward shift in the HA-contraction curve, these data suggest that the reduced reactivity involved, in part, a reduction in the ability of HA to increase the Ca2+ sensitivity of contractions. These data support the hypothesis that the degree of stimulus-induced Ca2+ sensitization of contractions is dependent on the history of receptor activation.


    ACKNOWLEDGEMENTS

The technical assistance of Paul-Michael Salomonsky is gratefully acknowledged. Also, my gratitude extends to Dr. Frank A. Lattanzio for access to his fluorometer.


    FOOTNOTES

This work was supported by a grant from the American Heart Association, Virginia Affiliate.

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.

Address for reprint requests and other correspondence: P. H. Ratz, Dept. of Physiological Sciences, Eastern Virginia Medical School, PO Box 1980, Norfolk, VA 23501 (E-mail: ratz{at}borg.evms.edu).

Received 31 December 1998; accepted in final form 24 May 1999.


    REFERENCES
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

1.   Bevan, J. A., and C. Su. Variation of intra- and perisynaptic adrenergic transmitter concentrations with the width of synaptic cleft in vascular tissue. J. Pharmacol. Exp. Ther. 190: 30-38, 1974[Abstract/Free Full Text].

2.   Bourne, H. R. Basic and Clinical Pharmacology (7th ed.). Norwalk, CT: Appleton and Lange, 1998, p. 9-33.

3.   Colucci, W. S., and R. W. Alexander. Norepinephrine-induced alteration in the coupling of alpha 1-adrenergic receptor occupancy to calcium efflux in rabbit aortic smooth muscle cells. Proc. Natl. Acad. Sci. USA 83: 1743-1746, 1986[Abstract/Free Full Text].

4.   Declerck, I., B. Himpens, G. Droogmans, and R. Casteels. The alpha 1-agonist phenylephrine inhibits voltage-gated Ca2+ channels in vascular smooth muscle cells of rabbit ear artery. Pflügers Arch. 417: 117-119, 1990[Medline].

5.   Fleming, W. W., D. P. Westfall, I. S. De La Lande, and L. B. Jellet. Log-normal distribution of equieffective doses of norepinephrine and acetylcholine in several tissues. J. Pharmacol. Exp. Ther. 181: 339-345, 1972[Abstract/Free Full Text].

6.   Fujihara, H., L. A. Walker, M. C. Gong, E. Lemichez, P. Boquet, A. V. Somlyo, and A. P. Somlyo. Inhibition of RhoA translocation and calcium sensitization by in vivo ADP-ribosylation with the chimeric toxin DC3B. Mol. Biol. Cell 8: 2437-2447, 1997[Abstract/Free Full Text].

7.   Grynkiewicz, G., M. Poenie, and R. Y. Tsien. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260: 3440-3450, 1985[Abstract/Free Full Text].

8.   Herlihy, J. T., and R. A. Murphy. Length-tension relationship of smooth muscle of the hog carotid artery. Circ. Res. 33: 257-283, 1973.

9.   Hishinuma, S., Y. Matsumoto, M. K. Uchida, and M. Kurokawa. Novel regulation of muscarinic receptors and their coupling with G proteins in smooth muscle: transient resensitization during desensitizing process. Br. J. Pharmacol. 109: 330-335, 1993[Medline].

10.   Huang, C., J. R. Hepler, A. G. Gilman, and S. M. Mumby. Attenuation of Gi- and Gq-mediated signaling by expression of RGS4 and GAIP in mammalian cells. Proc. Natl. Acad. Sci. USA 94: 6159-6163, 1997[Abstract/Free Full Text].

11.   Izzo, N. J., Jr., C. E. Seidman, S. Collins, and W. S. Colucci. alpha 1-Adrenergic receptor mRNA level is regulated by norepinephrine in rabbit aortic smooth muscle cells. Proc. Natl. Acad. Sci. USA 97: 6268-6271, 1990.

12.   Karaki, H. Ca2+ localization and sensitivity in vascular smooth muscle. Trends Pharmacol. Sci. 10: 320-325, 1989[Medline].

13.   Kawada, T., A. Toyosato, M. O. Islam, Y. Yoshida, and S. Imai. cGMP-kinase mediates cGMP- and cAMP-induced Ca2+ desensitization of skinned rat artery. Eur. J. Pharmacol. 323: 75-82, 1997[Medline].

14.   Lee, M. R., L. Lin, and T. Kitazawa. Cyclic GMP causes Ca2+ desensitization in vascular smooth muscle by activating the myosin light chain phosphatase. J. Biol. Chem. 272: 5063-5068, 1997[Abstract/Free Full Text].

15.   Leff, P., C. Scaramellini, C. Law, and K. McKechnie. A three-state receptor model of agonist action. Trends Pharmacol. Sci. 18: 355-362, 1997[Medline].

16.   Lurie, K. G., G. Tsujimoto, and B. B. Hoffman. Desensitization of alpha-1 adrenergic receptor-mediated vascular smooth muscle contraction. J. Pharmacol. Exp. Ther. 234: 147-152, 1985[Abstract/Free Full Text].

17.   Nishimura, J., M. Kolber, and C. van Breemen. Norepinephrine and GTP-gamma -S increase myofilament Ca2+ sensitivity in alpha -toxin permeabilized arterial muscle. Biochem. Biophys. Res. Commun. 157: 677-683, 1988[Medline].

18.   Owen, M. P. Functional characterization of alpha adrenoceptors on rabbit intrarenal arteries in vitro. J. Pharmacol. Exp. Ther. 265: 807-812, 1993[Abstract/Free Full Text].

19.   Perkins, J. P., W. P. Hausdorff, and R. J. Lefkowitz. Mechanisms of ligand-induced desensitization of beta-adrenergic receptors. In: The Beta-Adrenergic Receptors, edited by J. P. Perkins. Totowa, NJ: Humana, 1991, p. 73-124.

20.   Purdy, R. E., D. W. Ashbrook, G. L. Stupecky, and M. Y. Watanabe. Qualitative and quantitative differences between the postsynaptic alpha adrenoceptors of rabbit ear artery and thoracic aorta. J. Pharmacol. Exp. Ther. 224: 543-551, 1983[Abstract/Free Full Text].

21.   Ratz, P. H. High alpha 1-adrenoceptor occupancy decreases relaxing potency of nifedipine by increasing myosin light chain phosphorylation. Circ. Res. 72: 1308-1316, 1993[Abstract/Free Full Text].

22.   Ratz, P. H. Receptor activation induces short-term modulation of arterial contractions: Memory in vascular smooth muscle. Am. J. Physiol. 269 (Cell Physiol. 38): C417-C423, 1995[Abstract/Free Full Text].

23.   Ratz, P. H., M. M. Gleason, and S. F. Flaim. Simultaneous measurement of force and calcium uptake during acetylcholine-induced endothelium-dependent relaxation of rabbit thoracic aorta. Circ. Res. 60: 31-38, 1987[Abstract/Free Full Text].

24.   Ratz, P. H., and F. A. Lattanzio. L-type Ca2+ channel desensitization by F- reduces PhE-induced increase in [Ca2+]i but not stress. Am. J. Physiol. 262 (Cell Physiol. 31): C621-C627, 1992[Abstract/Free Full Text].

25.   Ratz, P. H., F. A. Lattanzio, Jr., and P.-M. Salomonsky. Memory of arterial receptor activation involves reduced [Ca2+]i and desensitization of cross bridges to [Ca2+]i. Am. J. Physiol. 269 (Cell Physiol. 38): C1402-C1407, 1995[Abstract/Free Full Text].

26.   Ross, E. M. Goodman and Gilman's Pharmacological Basis of Therapeutics (9th ed.). New York: McGraw-Hill, 1996, p. 29-41.

27.   Ruffolo, R. R., Jr., A. J. Nichols, J. M. Stadel, and J. P. Hieble. Structure and function of alpha -adrenoceptors. Pharmacol. Rev. 43: 475-505, 1991[Medline].

28.   Shenfeld, O. Z., C. W. Morgan, and P. H. Ratz. Bethanechol activates a post-receptor negative feedback mechanism in rabbit urinary bladder smooth muscle. J. Urol. 159: 252-257, 1998[Medline].

29.   Somlyo, A. P., and A. V. Somlyo. Signal transduction and regulation in smooth muscle. Nature 372: 231-236, 1994[Medline]

30.   Wardle, R. L., J. D. Strauss, C. M. Rembold, and R. A. Murphy. Heterologous desensitization of smooth muscle to K+ depolarization: retarded stimulus-[Ca2+]i coupling. Am. J. Physiol. 272 (Cell Physiol. 41): C1810-C1820, 1997[Abstract/Free Full Text].

31.   Yanagisawa, T., and Y. Okada. KCl depolarization increases Ca2+ sensitivity of contractile elements in coronary arterial smooth muscle. Am. J. Physiol. 267 (Heart Circ. Physiol. 36): H614-H621, 1994[Abstract/Free Full Text].


Am J Physiol Heart Circ Physiol 277(5):H1661-H1668
0002-9513/99 $5.00 Copyright © 1999 the American Physiological Society



This article has been cited by other articles:


Home page
Am. J. Physiol. Cell Physiol.Home page
M. Porter, M. C. Evans, A. S. Miner, K. M. Berg, K. R. Ward, and P. H. Ratz
Convergence of Ca2+-desensitizing mechanisms activated by forskolin and phenylephrine pretreatment, but not 8-bromo-cGMP
Am J Physiol Cell Physiol, June 1, 2006; 290(6): C1552 - C1559.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
P. H. Ratz, K. M. Berg, N. H. Urban, and A. S. Miner
Regulation of smooth muscle calcium sensitivity: KCl as a calcium-sensitizing stimulus
Am J Physiol Cell Physiol, April 1, 2005; 288(4): C769 - C783.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
N. H. Urban, K. M. Berg, and P. H. Ratz
K+ depolarization induces RhoA kinase translocation to caveolae and Ca2+ sensitization of arterial muscle
Am J Physiol Cell Physiol, December 1, 2003; 285(6): C1377 - C1385.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
G. Pfitzer
Signal Transduction in Smooth Muscle: Invited Review: Regulation of myosin phosphorylation in smooth muscle
J Appl Physiol, July 1, 2001; 91(1): 497 - 503.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ratz, P. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ratz, P. H.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online